Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Moon Surgical
Moon Surgical is a medical device company that aims to augment surgeons with computer vision, haptics, and robotics.
Sector
Subsector
Location
total rounds
total raised
CMR Surgical
CMR Surgical develops next-gen surgical robots for minimal access surgery.
Sector
Subsector
Keywords
Location
total rounds
total raised
OnPoint Surgical
OnPoint Surgical provides real-time intra-operative imaging technology for spinal surgery treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
Vicarious Surgical
Vicarious Surgical is a robotics company that aims to improve surgical procedures and patient outcomes while reducing healthcare costs.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds18
Number of Funding Rounds
Money Raised
Their latest funding was raised on 03.04.2024. Their latest investor Karl Storz. Their latest round Post-IPO Debt
Karl Storz
Karl Storz is a global manufacturer and distributor of endoscopes, medical instruments, and devices for human and veterinary medicine.
Sector
Subsector
Location
count Of Investments
Co-Investors
Investors12
Number of lead investors
Number of investors
Karl Storz
Karl Storz is a global manufacturer and distributor of endoscopes, medical instruments, and devices for human and veterinary medicine.
Sector
Subsector
Location
count Of Investments
Armentum Partners
Armentum Partners is a financial services firm specializing in debt capital solutions.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Synergy Life Science Partner
Synergy Life Science Partner invests in early-stage medical device and combination product companies in the U.S.
Sector
Subsector
Location
count Of Investments
count Of Exists
William Starling
William N. Starling is General Partner of Synergy Life Science Partners, LP (www.synergylsp.com) and Chief Executive Officer of Synecor, LLC, (Synecor) a business generator of new Life Science companies based in Research Triangle Park (RTP), North Carolina, Santa Rosa, California, and Portola Valley, California. As CEO of Synecor, William is a cofounder of BaroSense, Inc., Bioerodible Vascular Solutions, Inc., (acquired by Guidant/Abbott in April 2004), InnerPulse, Inc. (formerly Interventional Rhythm Management, Inc.), TransEnterix, Inc., and Interventional Autonomics Corporation, the initial five companies founded and incubated by Synecor. William currently serves as Chairman of the Board of InnerPulse Inc., a RTP, NC - based cardiac rhythm management company, Chairman of the Board of Interventional Autonomics Corporation, and as a board member of TransEnterix, Inc., a RTP, NC - based less invasive GI Surgery company. William received his BS degree from the University of North Carolina at Chapel Hill and his MBA degree from the University of Southern California. He was subsequently part of the founding management team and Director of Marketing for Advanced Cardiovascular Systems, Inc. (acquired by Guidant/Abbott), and was a cofounder, Vice President and Board member of Ventritex, Inc. (acquired by St. Jude Medical). In 1992, William was a cofounder and Chairman of the Board of Directors and President/CEO of Cardiac Pathways Corporation (acquired by Boston Scientific Corporation), William serves as Chairman of the Board of Visitors at the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill and a Board of Visitor member of the Lineberger Comprehensive Cancer Center at UNC.
current job
count Of Investments
Acquisitions2
MST Medical Surgery Technologies acquired by Asensus Surgical
acquirer
date
type
MST Medical Surgery Technologies
MST develops surgical analytics and image analytics technology for medical robotics and computer-assisted surgery..
Sector
Subsector
Keywords
Location
total rounds
total raised
SOFAR acquired by Asensus Surgical
acquirer
date
type
price
SOFAR
SOFAR
Location
People
Founders1
Richard Stack
Richard Stack is a co-founder of Synergy Life Science Partners. Additionally, Richard is President of Synecor, LLC, a business generator and financial incubator of new medical device companies. In the past six years, Richard has co-founded and invested in five major medical device companies, including Synecor. Richard chairs the scientific advisory board, leads the pre-clinical testing services provided and is the interim President of each Synecor spinout company. Richard is recognized as an international thought leader in the medical technology field. He has authored over 360 manuscripts, book chapters and scientific abstracts. He has been a principal and co-principal investigator of three NIH grants and received numerous research awards during his career including the International Award for Best Interventional Cardiology Experimental Research (1995, Netherlands). Richard has invented and/or invested in numerous technologies that have become widely adopted by physicians the world over. He has over 100 worldwide patents issued or pending on a wide variety of medical devices. Richard is a co-founder of BaroSense, InnerPulse and TransEnterix. Additionally, Richard serves on the Board of Directors and is the Scientific Advisory Board Chairman of BaroSense. Richard is Professor Emeritus of Medicine in Cardiology at Duke University in Durham, North Carolina, where he spent his entire academic medical career, since 1981, as Founder and Director of Duke Interventional Cardiology. Richard retired early from his academic career to join the investment community with the formation of Synecor, LLC in 2000.
current job
Richard Stack
Employee Profiles16
Shameze Rampertab
Executive Vice President and Chief Financial Officer
Anthony Fernando
President & Chief Executive Officer
Activity
Recent News6
The graph reveals the ratio (%) of positive news articles in a chosen time range